{"transactions":[{"id":692927,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:15:38.000Z","date":"2026-07-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.477,"value":7385.0,"ownership":{"direct":true},"balance_after":35201,"source":{"system":"sec-edgar","filing":"0001493152-26-036585","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000149315226036585/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-23"}},{"id":692697,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25314,"kind":"person","name":"Dempsey Robert John","position":1,"cik":"0002125298","reported_name":"Dempsey Robert John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:15:36.000Z","date":"2026-07-22","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.539,"value":23085.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001493152-26-036584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849296/000149315226036584/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-23"}},{"id":692952,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:15:35.000Z","date":"2026-07-21","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":1.4,"value":4900.0,"ownership":{"direct":true},"balance_after":112420,"source":{"system":"sec-edgar","filing":"0001493152-26-036583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000149315226036583/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-23"}},{"id":693371,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:15:33.000Z","date":"2026-07-21","kind":"purchase","planned":false,"acquired":true,"shares":22500,"price":1.45,"value":32625.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":10873916,"source":{"system":"sec-edgar","filing":"0001493152-26-036579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315226036579/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-23"}},{"id":693370,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:15:32.000Z","date":"2026-07-20","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.4,"value":35000.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":10851416,"source":{"system":"sec-edgar","filing":"0001493152-26-036582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315226036582/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-21"}},{"id":692696,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25313,"kind":"person","name":"Mantelli Flavio","position":1,"cik":"0002127572","reported_name":"Mantelli Flavio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:15:30.000Z","date":"2026-07-21","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.4,"value":28000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-26-036580","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849296/000149315226036580/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-22"}},{"id":692695,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25312,"kind":"person","name":"Patil Rajkumar V.","position":1,"cik":"0002124067","reported_name":"Patil Rajkumar V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:15:29.000Z","date":"2026-07-27","kind":"purchase","planned":false,"acquired":true,"shares":3363,"price":1.49,"value":5010.87,"ownership":{"direct":true},"balance_after":20030,"source":{"system":"sec-edgar","filing":"0001493152-26-036581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849296/000149315226036581/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-29"}},{"id":701229,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25312,"kind":"person","name":"Patil Rajkumar V.","position":1,"cik":"0002124067","reported_name":"Patil Rajkumar V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"COMMON STOCK","published_at":"2026-07-29T20:45:21.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":3363,"price":1.49,"value":5010.87,"ownership":{"direct":true},"balance_after":20030,"source":{"system":"sec-edgar","filing":"0001493152-26-035212","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849296/000149315226035212/ownership.xml","form_type":"4"}},{"id":703875,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25314,"kind":"person","name":"Dempsey Robert John","position":1,"cik":"0002125298","reported_name":"Dempsey Robert John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"COMMON STOCK","published_at":"2026-07-23T20:20:26.000Z","date":"2026-07-22","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":1.539,"value":23085.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001493152-26-034409","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849296/000149315226034409/ownership.xml","form_type":"4"}},{"id":704173,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2026-07-23T20:15:26.000Z","date":"2026-07-21","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":1.45,"value":32625.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":10873916,"source":{"system":"sec-edgar","filing":"0001493152-26-034408","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315226034408/ownership.xml","form_type":"4"}},{"id":703963,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"COMMON STOCK","published_at":"2026-07-23T20:15:25.000Z","date":"2026-07-21","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":1.4,"value":4900.0,"ownership":{"direct":true},"balance_after":112420,"source":{"system":"sec-edgar","filing":"0001493152-26-034406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000149315226034406/ownership.xml","form_type":"4"}},{"id":703959,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2026-07-23T20:15:24.000Z","date":"2026-07-21","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":1.477,"value":7385.0,"ownership":{"direct":true},"balance_after":35201,"source":{"system":"sec-edgar","filing":"0001493152-26-034405","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000149315226034405/ownership.xml","form_type":"4"}},{"id":704454,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25313,"kind":"person","name":"Mantelli Flavio","position":1,"cik":"0002127572","reported_name":"Mantelli Flavio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"COMMON STOCK","published_at":"2026-07-22T20:15:21.000Z","date":"2026-07-21","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":1.4,"value":28000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-26-034236","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849296/000149315226034236/ownership.xml","form_type":"4"}},{"id":705305,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2026-07-21T20:15:01.000Z","date":"2026-07-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":1.4,"value":35000.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":10851416,"source":{"system":"sec-edgar","filing":"0001493152-26-034084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315226034084/ownership.xml","form_type":"4"}},{"id":742800,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":39591,"kind":"person","name":"Denoyer Bernard","position":1,"cik":"0001397636","reported_name":"Denoyer Bernard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2026-06-10T21:00:07.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":1.85,"value":6475.0,"ownership":{"direct":true},"balance_after":35190,"derivative":{"exercise_price":1.85,"exercise_date":"2027-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001493152-26-028134","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1397636/000149315226028134/ownership.xml","form_type":"4"}},{"id":742891,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2026-06-10T21:00:05.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":1.85,"value":12025.0,"ownership":{"direct":true},"balance_after":138394,"derivative":{"exercise_price":1.85,"exercise_date":"2027-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001493152-26-028133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000149315226028133/ownership.xml","form_type":"4"}},{"id":742974,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":39630,"kind":"person","name":"Simon Willy Jules","position":1,"cik":"0001325410","reported_name":"Simon Willy Jules","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2026-06-10T21:00:04.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":1.85,"value":12025.0,"ownership":{"direct":true},"balance_after":135502,"derivative":{"exercise_price":1.85,"exercise_date":"2027-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001493152-26-028132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325410/000149315226028132/ownership.xml","form_type":"4"}},{"id":742510,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":39522,"kind":"person","name":"Shah Keeren Rameshchandra","position":1,"cik":"0002125071","reported_name":"Shah Keeren Rameshchandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option","published_at":"2026-06-10T21:00:02.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":1.85,"value":74000.0,"ownership":{"direct":true},"balance_after":544819,"derivative":{"exercise_price":1.85,"exercise_date":"2027-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-26-028131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849296/000149315226028131/ownership.xml","form_type":"4"}},{"id":743524,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2026-06-10T20:30:22.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":1.72,"value":516000.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":10826416,"source":{"system":"sec-edgar","filing":"0001493152-26-028117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315226028117/ownership.xml","form_type":"4"}},{"id":1753283,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2023-10-31T20:15:10.000Z","date":"2023-10-27","kind":"other","planned":false,"acquired":true,"shares":70071,"price":1.5,"value":105106.5,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents ordinary shares issued in lieu of cash payment to the Reporting Person."}],"balance_after":9177903,"source":{"system":"sec-edgar","filing":"0001493152-23-038854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315223038854/ownership.xml","form_type":"4"}},{"id":1753282,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2023-10-31T20:15:10.000Z","date":"2023-10-23","kind":"other","planned":false,"acquired":true,"shares":499468,"price":1.5,"value":749202.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares received in satisfaction of bonus"}],"balance_after":9107832,"source":{"system":"sec-edgar","filing":"0001493152-23-038854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315223038854/ownership.xml","form_type":"4"}},{"id":1772055,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25396,"kind":"person","name":"BRANCACCIO JOHN P","position":1,"cik":"0001276551","reported_name":"BRANCACCIO JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-09-28T10:15:12.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":16670,"price":1.5,"value":25005.0,"ownership":{"direct":true},"balance_after":16670,"source":{"system":"sec-edgar","filing":"0001493152-23-034486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276551/000149315223034486/ownership.xml","form_type":"4"}},{"id":2262246,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2022-05-20T14:35:57.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":5800000,"price":0.076,"value":440800.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":548981215,"source":{"system":"sec-edgar","filing":"0001493152-22-014552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315222014552/ownership.xml","form_type":"4"}},{"id":2263430,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25405,"kind":"person","name":"JACOB GARY S","position":1,"cik":"0001266802","reported_name":"JACOB GARY S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"American Depositary Shares","published_at":"2022-05-19T15:14:55.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":12500,"price":4,"value":50000.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001493152-22-014438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266802/000149315222014438/ownership.xml","form_type":"4"}},{"id":2264169,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Non-Executive Chairman"}}],"security":"American Depositary Shares","published_at":"2022-05-19T15:14:51.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":37500,"price":4,"value":150000.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":62500,"source":{"system":"sec-edgar","filing":"0001493152-22-014437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315222014437/ownership.xml","form_type":"4"}},{"id":2266089,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Non-Executive Chairman"}}],"security":"American Depositary Shares","published_at":"2022-05-18T17:38:50.000Z","date":"2022-05-17","kind":"purchase","acquired":true,"shares":25000,"price":3.87,"value":96750.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001493152-22-014299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315222014299/ownership.xml","form_type":"4/A","original_submission_date":"2022-05-18"}},{"id":2266088,"issuer":{"id":6916,"kind":"organization","name":"OKYO Pharma Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Non-Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2022-05-18T15:37:20.000Z","date":"2022-05-17","kind":"purchase","acquired":true,"shares":1625000,"price":0.0595,"value":96687.5,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":544806215,"source":{"system":"sec-edgar","filing":"0001493152-22-014284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000149315222014284/ownership.xml","form_type":"4"}}]}